NCT07185594View on ClinicalTrials.gov

A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery

PHASE2/PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

January 31, 2026

Conditions
Postoperative Analgesia
Interventions
DRUG

HRS-2129 Tablets

HRS-2129 tablets.

DRUG

Blank Preparation.

Blank preparation.

DRUG

Tramadol Hydrochloride SR Tablets

Tramadol Hydrochloride SR tablets.

Trial Locations (2)

310009

The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou

450052

The First Affiliated Hospital of Zhengzhou University, Zhengzhou

All Listed Sponsors
lead

Shandong Suncadia Medicine Co., Ltd.

INDUSTRY

NCT07185594 - A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery | Biotech Hunter | Biotech Hunter